Click the button below to contact us or submit your feedback about this product.
This product is a conjugated anti-Human CD99 Monoclonal antibody (MEM-131) generated from the Mouse. This antibody can be used for WB, FC, IHC, IP.
Please feel free to contact us for a quote and further discussion with our scientists. Datasheets
specifications |
|
---|---|
Antibody Isotype | IgM |
Clone | MEM-131 |
Applications | WB; FC; IHC; IP |
Target | CD99 |
Epitope | This antibody recognizes an epitope restricted to a subset of CD99 molecule expressed on myeloid cells, NK cells and T lymphocytes. |
Host | Mouse |
Clonality | Monoclonal |
Antibody Type | Primary antibody |
Species Reactivity | Human |
Immunogen | HPB-ALL human peripheral blood leukemia T-cell line |
Format | Liquid |
Buffer | TBS with BSA |
Storage | Store at 4° C in dark. Do not freeze. |
Target Information |
|
---|---|
Target Name | CD99 |
Alternative Names | CD99 Molecule (Xg Blood Group); CD99 Antigen; T-Cell Surface Glycoprotein E2; E2 Antigen; MIC2X; MIC2Y; MIC2; Antigen Identified By Monoclonal 12E7, Y Homolog; MIC2 (Monoclonal Antibody 12E7); Cell Surface Antigen HBA-71; Cell Surface Antigen 12E7; Cell Surface Antigen O13; Surface Antigen MIC2; CD99 Molecule; Protein MIC2; HBA71; MSK5X; CD99; 12E7 |
Related Disease | Ewing Sarcoma; Lymphoblastic Lymphoma |
Gene ID | 4267 |
UniProt ID | P14209 |
Target Overview | Involved in T-cell adhesion processes and in spontaneous rosette formation with erythrocytes. Plays a role in a late step of leukocyte extravasation helping leukocytes to overcome the endothelial basement membrane. Acts at the same site as, but independently of, PECAM1. Involved in T-cell adhesion processes. |
Click the button below to contact us or submit your feedback about this product.
KINDLY NOTE
!! For Research Use Only. Our products and services are NOT intended for diagnostic or therapeutic applications.
!! Custom antibodies beyond the list can be tailored flexibly. Please directly Email us your specific demands.
© 2024 Creative Biolabs All Rights Reserved